Literature DB >> 8397999

Antihypertensive medication-taking. Investigation of a simple regimen.

D Guerrero1, P Rudd, C Bryant-Kosling, B Middleton, B ] Middleton BF [corrected to Middleton.   

Abstract

In search of strategies to improve compliance, we assessed medication-taking behavior among 19 ambulatory hypertensives, using both pill counts and electronic monitoring. The regimen consisted of one pill each day for < or = 63 weeks with return visits at 1 to 4 week intervals. The study population was 79% male, 68% white, and 16% black with mean (+/- SEM) age 58.4 +/- 2.5 years. Only 51% of the intervisit intervals displayed > or = 80% of vial openings within the desirable range (24 +/- 6 h). Pill counts detected only 2% of suboptimal interdosing intervals identified by electronic monitoring. Early changes in compliance correlated well with later changes (r = 0.83, P = .002). A few of the subjects exhibited a large deviation from the prescription, uncorrectable with drugs having a long duration of action. We conclude that (a) pill counts tend to overestimate patients' compliance rates; (b) changes in medication-taking behavior early in therapy may predict subsequent compliance rates; and (c) prolonging drug action may compensate for some imperfect medication-taking behavior.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397999     DOI: 10.1093/ajh/6.7.586

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  11 in total

1.  The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response.

Authors:  John Urquhart
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

Review 2.  The electronic medication event monitor. Lessons for pharmacotherapy.

Authors:  J Urquhart
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

Review 3.  A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence.

Authors:  Mohamed El Alili; Bernard Vrijens; Jenny Demonceau; Silvia M Evers; Mickael Hiligsmann
Journal:  Br J Clin Pharmacol       Date:  2016-05-02       Impact factor: 4.335

4.  Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study.

Authors:  R Nuesch; K Schroeder; T Dieterle; B Martina; E Battegay
Journal:  BMJ       Date:  2001-07-21

Review 5.  Some economic consequences of noncompliance.

Authors:  J Urquhart
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

6.  Symptoms of depression and anxiety and adherence to antihypertensive medication.

Authors:  Leonelo E Bautista; Lina M Vera-Cala; Cynthia Colombo; Paul Smith
Journal:  Am J Hypertens       Date:  2012-01-19       Impact factor: 2.689

7.  Patient compliance and therapeutic coverage: comparison of amlodipine and slow release nifedipine in the treatment of hypertension. The Belgian Collaborative Study Group.

Authors:  J M Detry; P Block; G De Backer; J P Degaute
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

8.  Drug Side Effect Symptoms and Adherence to Antihypertensive Medication.

Authors:  Yacob G Tedla; Leonelo E Bautista
Journal:  Am J Hypertens       Date:  2015-12-07       Impact factor: 2.689

Review 9.  Role of patient compliance in clinical pharmacokinetics. A review of recent research.

Authors:  J Urquhart
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

10.  Intensifying therapy for hypertension despite suboptimal adherence.

Authors:  Adam J Rose; Dan R Berlowitz; Meredith Manze; Michelle B Orner; Nancy R Kressin
Journal:  Hypertension       Date:  2009-07-06       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.